))
Episode 18 - Issues with Treatments
Manage episode 413818591 series 3506573
Conteúdo fornecido por Debbie and Elyse. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Debbie and Elyse ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode, we’re talking about some issues with treatments. We’re looking at some drugs that have lost or might lose their approvals, or cases where additional measures are put in place for safety reasons.
Here are some resources or references used in the research for this episode -
Crizanlizumab statement. January 2024 » Sickle Cell Society
Crizanlizumab - end of NHS supply » Sickle Cell Society
FDA starts speedy review of Novartis’ sickle cell antibody - PMLiVE
Exa-Cel (Casgevy) Gene Therapy Update » Sickle Cell Society
Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions - GOV.UK (www.gov.uk)
Remember, you can get in touch with us via clinical.research.intro@gmail.com. Please feel free to send questions, comments and compliments for Elyse to read out on the pod. It’s fun to make Debbie squirm!
Credit to our friend Sam Winnie for their awesome and cute music. Check out their work at https://www.samwinnie.com/
19 episódios
Compartilhar
